NCA Upper Gastrointestinal Pathway Board (NCUGIPB)
Upper Gastrointestinal (GI) Pathway Board
The Pathway Board brings together healthcare professionals, clinical leaders, and multi-agency representatives to enhance patient outcomes, ensure service quality, and promote equitable care across the region.
Upper GI cancer in the North of Scotland
Upper GI cancers account for around 1500 new diagnosis in Scotland each year. Upper GI cancers include of the Oesophagus (gullet) and Stomach (gastric).
In the North, investigation and treatment of Upper GI cancers occurs in our three main cancer centres in Aberdeen, Dundee and Inverness.
The aim of this Pathway Board is to facilitate regional working between the centres, ensuring a focus on improving patient outcomes.
For more information on the symptoms, investigation and treatment of Upper GI cancers, please visit the NHS Inform website.
Pathway Board details
| Clinical Director | Professor Russell Petty, Consultant Clinical Oncologist, NHS Tayside |
| Terms of Reference | In Development |
Clinical Management Guidelines (CMGs)
| Title | Published |
| Gastric Cancer | November 2017 - under review |
| Oesophageal Cancer | November 2017 - under review |
Other guidelines
|
Scottish Cancer Referral Guidelines - Ooesophago-gastric Cancers |
North of Scotland Quality Performance Indicator (QPI) Annual Reports
Quality Performance Indicator (QPI) National Reports
| Upper GI Cancer QPI National Report (2013-15 patients) |